Director, Toxicology
Company: Bolt Biotherapeutics
Location: Redwood City
Posted on: January 25, 2023
|
|
Job Description:
Who We AreBolt Biotherapeutics, based in the San Francisco Bay
Area, is a clinical-stage biotechnology company developing Boltbody
Immune-stimulating Antibody Conjugates (ISACs), a new class of
immuno-oncology therapeutics. This is a unique opportunity to join
and build, with like-minded colleagues, a company that will
transform the lives of individuals with cancers.The PositionWe are
seeking a scientifically minded toxicologist to join our
Preclinical Safety Assessment function to provide scientific and
hands-on support to our immune-stimulating antibody conjugate
(ISAC) drug development programs, from target validation, candidate
selection, IND filing through clinical stages. The incumbent will
work with immunologists, tumor biologists, chemists, DMPK and
clinicians on several cancer drug development programs over a wide
range of development stages, be the in-house expert on toxicology
investigations and regulatory reporting while utilizing appropriate
external resources. We welcome pathologists who would like to
expand their professional horizon to preclinical toxicology and
regulatory filing. We equally welcome toxicologists who have a
passion in biology and scientific research. This role will report
to the Vice President, Development Sciences.Key
ResponsibilitiesServe as Preclinical Safety Assessment project team
representative on multi-disciplinary Discovery and Development
teams responsible for the progression of both ISAC and monoclonal
antibody biotherapeutics. These activities include:--- Support
Discovery projects through the development of exploratory
toxicology strategy and its execution--- Design preclinical safety
assessment strategy, including in vitro, in vivo and ex vivo
testing--- Design and interpret safety pharmacology and toxicity
studies by coordinating internal and external resources--- Active
member on project teams--- Prepare and/or review safety
pharmacology and toxicology reports--- Author the nonclinical
document sections for regulatory submissions (including CIBs INDs,
MAAs, CTAs, CTDs and BLAs)--- Participate in issue-resolution
teams, where they will be required to contribute to hypotheses
generation and drive the science for toxicology issue resolution in
drug discovery and development--- Participate in special projects
or inter-industry working groups, as needed--- Provide scientific
input on design and analysis of research activities--- Identify and
leverage external experts in scientific issues related to
nonclinical safety assessment--- Ensure high scientific standards
and adhering to requested timelines in all aspects of the
positionQualifications --- Ph.D. or equivalent in pathology,
toxicology, or related disciplines--- DACVP DABT or DVM is highly
preferred--- 6+ years of industry experience with biologics
focuses; experience in immunology and cancer immunology is highly
valued; experience in ADC development is valued; experience in
immunogenicity of biologics is also valued--- Inter-departmental
research interests and the ability to initiate, collaborate and
lead teams to address scientific issues--- Experience in
interacting with the US and/or international health authorities---
Familiarity with GLP regulations preferred We are an Equal
Opportunity Employer offering a competitive salary and benefits
package. Applicants should be legally entitled to work for any
employer in the US. Bolt Biotherapeutics requires all U.S. new
hires to be fully vaccinated for COVID-19 prior to the first date
of employment. As required by applicable law, Bolt will consider
requests for Reasonable Accommodations. Note to Employment
Agencies: Please do not forward any agency resumes. The company
will not be responsible for any fees related to resumes that are
unsolicited.
Keywords: Bolt Biotherapeutics, Redwood City , Director, Toxicology, Executive , Redwood City, California
Click
here to apply!
|